Patents Assigned to Qiagen Sciences, LLC
-
Patent number: 10844430Abstract: The present invention provides methods, compositions, mixtures and kits utilizing 5-Chloro-2-methyl-4-isothiazolin-3-one in sequencing reactions, and in particular, sequencing reactions where deoxynucleoside triphosphates comprising a 3?-O position capped by a disulfide-based 3?-terminator group are used. In one embodiment, the deoxynucleoside triphosphates comprise a 3?-O position capped by a group comprising methylenedisulfide as a cleavable protecting group and a detectable label reversibly connected to the nucleobase of said deoxynucleoside. In addition, thiol-containing compounds and scavengers of thio-containing compounds are described. Such compounds provide new possibilities for future sequencing technologies, including but not limited to Sequencing by Synthesis.Type: GrantFiled: January 24, 2018Date of Patent: November 24, 2020Assignee: Qiagen Sciences, LLCInventors: Luisa Andruzzi, Jimmy Adediran, Timothy Pelletier, Austin Ricker, Angela DeLucia, Ben McNally, Dona Hevroni, Mong Sano Marma, John Andrew Sheridan
-
Patent number: 10760120Abstract: The present disclosure provides methods and kits for performing high multiplex PCR using molecular barcodes. The methods disclosed herein separately extend a set of primers (BC primers) that each comprise a target-specific sequence, a molecular barcode and a universal sequence, and amplify the resulting extension products using another set of primers (LA primers) that each comprise another target-specific sequence and a universal sequence. The methods may further comprise amplification using universal primers (preferably comprising an adapter).Type: GrantFiled: January 21, 2016Date of Patent: September 1, 2020Assignee: QIAGEN SCIENCES, LLCInventors: Yexun Wang, Quan Peng
-
Patent number: 10745740Abstract: The invention provides methods and compositions, including, without limitation, algorithms, computer readable media, computer programs, apparatus, and systems for determining the identity of nucleic acids in nucleotide sequences using, for example, data obtained from sequencing by synthesis methods. The methods of the invention include correcting one or more phenomena that are encountered during nucleotide sequencing, such as using sequencing by synthesis methods. These phenomena include, without limitation, sequence lead, sequence lag, spectral crosstalk, and noise resulting from variations in illumination and/or filter responses.Type: GrantFiled: May 20, 2013Date of Patent: August 18, 2020Assignee: Qiagen Sciences, LLCInventors: Steven Gordon, Phillip A Veatch
-
Patent number: 10655171Abstract: Modular flow cells, devices with modular flow cells, and methods of sequencing using modular flow cells, as well as systems and kits including modular flow cells, are described, permitting sequencing wherein less than the full capacity for sequencing is desired.Type: GrantFiled: November 6, 2018Date of Patent: May 19, 2020Assignees: QIAGEN SCIENCES, LLC, QIAGEN GmbHInventors: Jerzy Olejnik, Dirk Zimmermann
-
Patent number: 10656164Abstract: A method of determining risk of preterm labor in an asymptomatic pregnant woman can include: obtaining a vaginal fluid sample from an asymptomatic pregnant woman; contacting the vaginal fluid sample with a PAMG-1 antibody that binds with PAMG-1; detecting whether the PAMG-1 antibody binds with PAMG-1 in the vaginal fluid sample to form a PAMG-1-antibody complex; and providing the determined risk to the pregnant woman. When the PAMG-1-antibody complex forms, the asymptomatic pregnant woman is determined to be susceptible to preterm labor because PAMG-1 is detected in the vaginal sample. When the PAMG-1-antibody complex does not form, the asymptomatic pregnant woman is determined to be not susceptible to preterm labor because the PAMG-1 is not detected in the vaginal sample.Type: GrantFiled: December 21, 2017Date of Patent: May 19, 2020Assignee: Qiagen Sciences, LLCInventors: Ruben Salinas, Anthony Ausiello
-
Patent number: 10626446Abstract: Methods and compositions for enriching a population of particles containing an analyte are disclosed. In one embodiment, enrichment beads are used that are larger in size than the beads used for amplification. A separation device is employed that can retain larger beads with bound amplified beads. The technique finds many uses, including enriching for beads with clonally amplified template, which can be used in a variety of assays, including nucleic acid sequencing.Type: GrantFiled: November 1, 2018Date of Patent: April 21, 2020Assignee: QIAGEN SCIENCES, LLCInventors: Jerzy Olejnik, Steven Gordon, Martina Werner
-
Patent number: 10544447Abstract: The present disclosure provides methods, arrays and kits for assessing the quality of genomic DNA samples, especially those obtained from formalin-fixed paraffin-embedded (FFPE) samples. The methods, arrays and kits provided herein use primer pairs specific to regions in the genomes of the organisms from which genomic DNA samples are obtained that have identical or nearly identical copies distributed across multiple chromosomes.Type: GrantFiled: April 29, 2019Date of Patent: January 28, 2020Assignee: QIAGEN Sciences, LLCInventors: Yexun Wang, John DiCarlo, Vikram Devgan, Qiong Jiang, Quan Peng
-
Patent number: 10519498Abstract: The invention relates to methods, compositions, devices, systems and kits are described including, without limitation, reagents and mixtures, for determining the identity of nucleic acids in nucleotide sequences using, for example, data obtained from sequencing by synthesis methods.Type: GrantFiled: February 8, 2017Date of Patent: December 31, 2019Assignee: Qiagen Sciences, LLCInventor: James J. DiMeo
-
Patent number: 10495443Abstract: Fiducial marking systems provided for forming a global coordinate system for a visual system having a limited field of view. The fiducial marking system includes a target surface that is movable relative to the visual system and a visual pattern associated with the target surface. The visual pattern includes a plurality of first lines and a plurality of second lines. Each first line is spaced by a first distance from each adjacent first line and each second line is spaced by a second distance from each adjacent second line, wherein the first distance is different than the second distance. Additionally, the first distance and the second distance are selected such that at least one first line and at least one second line are within the field of view at all relative positions of the visual system and the target surface.Type: GrantFiled: July 26, 2018Date of Patent: December 3, 2019Assignee: Qiagen Sciences, LLCInventors: Hsu-Yi Lee, Michel Georges Perbost
-
Patent number: 10472382Abstract: The invention provides methods and compositions, including, without limitation, algorithms, computer readable Media, computer programs, apparatus, and systems for determining the identity of nucleic acids in nucleotide sequences using, for example, data obtained from sequencing by synthesis methods. The methods of the invention include correcting one or more phenomena that are encountered during nucleotide sequencing, such as using sequencing by synthesis methods. These phenomena include, without limitation, sequence lead, sequence lag, spectral crosstalk, and noise resulting from variations in illumination and/or filter responses.Type: GrantFiled: November 16, 2018Date of Patent: November 12, 2019Assignee: QIAGEN SCIENCES, LLCInventors: Steven Gordon, Jerzy Olejnik
-
Patent number: 10422802Abstract: The present invention relates to a diagnostic method for the detection of small quantities of amniotic fluid in the vagina. More specifically, the invention relates to the detection of PAMG-1 in the vagina using anti-PAMG-1 antibodies.Type: GrantFiled: July 22, 2016Date of Patent: September 24, 2019Assignee: Qiagen Sciences, LLCInventors: Boris Fuks, Dmitrii D. Petrunin, Evgeny I. Zaraisky, Marina N. Boltovskaya, Svetlana V. Nazimova, Nelly A. Starosvetskaya, Alexandr Konstantinov, Margarita I. Marshiskaia
-
Patent number: 10336785Abstract: The present invention provides methods, compositions, mixtures and kits utilizing deoxynucleoside triphosphates comprising a 3?-O position capped by a group comprising methylenedisulfide as a cleavable protecting group and a detectable label reversibly connected to the nucleobase of said deoxynucleoside. Such compounds provide new possibilities for future sequencing technologies, including but not limited to Sequencing by Synthesis.Type: GrantFiled: November 4, 2016Date of Patent: July 2, 2019Assignee: Qiagen Sciences, LLCInventors: Mong Sano Marma, Jerzy Olejnik, Ilia Korboukh
-
Patent number: 10337050Abstract: The invention relates to methods, compositions, devices, systems and kits as described including, without limitation, reagents and mixtures for determining the identity of nucleic acids in nucleotide sequences using, for example, sequencing by synthesis methods. In particular, the present invention contemplates the use of polyphenolic compounds, known as antioxidant additives, to improve the efficiency of Sequencing-By-Synthesis reactions. For example, gallic acid (GA) is shown herein to be one of many exemplary SBS polyphenolic additives.Type: GrantFiled: February 8, 2017Date of Patent: July 2, 2019Assignee: Qiagen Sciences, LLCInventors: Jerzy Olejnik, Michel Georges Perbost
-
Patent number: 10316351Abstract: The present disclosure provides methods, arrays and kits for assessing the quality of genomic DNA samples, especially those obtained from formalin-fixed paraffin-embedded (FFPE) samples. The methods, arrays and kits provided herein use primer pairs specific to regions in the genomes of the organisms from which genomic DNA samples are obtained that have identical or nearly identical copies distributed across multiple chromosomes.Type: GrantFiled: March 13, 2018Date of Patent: June 11, 2019Assignee: QIAGEN Sciences, LLCInventors: Yexun Wang, John DiCarlo, Vikram Devgan, Qiong Jiang, Quan Peng
-
Patent number: 10301346Abstract: The present invention provides methods, compositions, mixtures and kits utilizing deoxynucleoside triphosphates comprising a 3?-O position capped by a group comprising methylenedisulfide as a cleavable protecting group and a detectable label reversibly connected to the nucleobase of said deoxynucleoside. Such compounds provide new possibilities for future sequencing technologies, including but not limited to Sequencing by Synthesis.Type: GrantFiled: November 4, 2016Date of Patent: May 28, 2019Assignee: Qiagen Sciences, LLCInventors: Mong Sano Marma, Jerzy Olejnik, Ilia Korboukh
-
Patent number: 10273539Abstract: The present invention provides methods, compositions, mixtures and kits utilizing deoxynucleoside triphosphates comprising a 3?-O position capped by a group comprising methylenedisulfide as a cleavable protecting group and a detectable label reversibly connected to the nucleobase of said deoxynucleoside. Such compounds provide new possibilities for future sequencing technologies, including but not limited to Sequencing by Synthesis.Type: GrantFiled: November 4, 2016Date of Patent: April 30, 2019Assignee: QIAGEN SCIENCES, LLCInventors: Mong Sano Marma, Jerzy Olejnik
-
Patent number: 10249038Abstract: A DNA flow cell processing method including positioning the flow cell on a stage at a predetermined location relative to a camera, illuminating the flow cell from a side with a first light source to reflect light off the DNA fragment bead locations, obtaining a first image of the flow cell and identifying a first reference pattern of bead locations in the first image, moving at least one of the flow cell and the stage relative to the camera, attempting to reposition the stage at the predetermined location, obtaining a second image of the flow cell, identifying the first reference pattern in the second image, and evaluating a first offset, relative to the camera, between the first reference pattern in the first image and the first reference pattern in the second image.Type: GrantFiled: January 23, 2017Date of Patent: April 2, 2019Assignee: Qiagen Sciences, LLCInventors: David Ray Stoops, Phillip Alan Veatch, Steven Jeffrey Gordon
-
Publication number: 20190071665Abstract: Provided are methods for isolating biomolecules, such as nucleic acids and proteins, from a sample using a silica-containing surface and/or a high salt, low pH buffer.Type: ApplicationFiled: September 2, 2016Publication date: March 7, 2019Applicant: Qiagen Sciences LLCInventors: Heather CALLAHAN, Eddie ADAMS, Mark N. BROLASKI, Victoria NIECIECKI
-
Patent number: 10222349Abstract: The invention provides methods and compositions, including, without limitation, algorithms, computer readable media, computer programs, apparatus, and systems for determining the identity of nucleic acids in nucleotide sequences using, for example, data obtained from sequencing by synthesis methods. A plurality of smaller flow cells is employed, each with a relatively small area to be imaged, in order to provide greater flexibility and efficiency.Type: GrantFiled: July 21, 2017Date of Patent: March 5, 2019Assignee: QIAGEN SCIENCES, LLCInventors: Steven Gordon, Thomas Hagerott, Edmund Golaski, Jerzy Olejnik
-
Patent number: 10160998Abstract: The present disclosure provides methods, compositions, and kits for performing PCR (including multiplex PCR). The methods, compositions and kits provided herein use one or more primer pairs that contain one or more cleavable bases located at a minimal distance away from the 3? termini of the primers, and increase the accuracy of downstream analysis of sequence data.Type: GrantFiled: February 5, 2015Date of Patent: December 25, 2018Assignee: QIAGEN Sciences, LLCInventor: Ravi Vijaya Satya